Early Use of Levosimendan Compared to Usual Care in Advanced Chronic Heart Failure (ACHF).

Trial Profile

Early Use of Levosimendan Compared to Usual Care in Advanced Chronic Heart Failure (ACHF).

Discontinued
Phase of Trial: Phase III

Latest Information Update: 12 Apr 2017

At a glance

  • Drugs Levosimendan (Primary) ; Furosemide
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Acronyms ELEVATE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Apr 2017 Status changed from suspended to discontinued.
    • 28 Mar 2017 Planned End Date changed from 1 Dec 2015 to 1 Mar 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top